Clinical Trial Update: Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating WJ-derived mesenchymal stem cells with parathyroid hormone for vertebral compression fractures; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporotic Fractures
• Vertebral Compression Fracture

Drugs mentioned

• Parathyroid hormone (Parathyroid hormone)
• WJ-derived mesenchymal stem cells (mesenchymal stem cells derived from Wharton's jelly)

Snippet

Sponsor: Inbo Han | Conditions: Vertebral Compression Fracture, Osteoporotic Fractures | Phase 2 | Status: UNKNOWN